Inozyme Pharma Announces Publication of Comprehensive ENPP1

Inozyme Pharma Announces Publication of Comprehensive ENPP1 Variant Database

31.10.2022 - - Peer-reviewed article in Human Mutation reports 3-fold increase in pathogenic/likely pathogenic ENPP1 variants – - Database identified severely symptomatic patients with monoallelic heterozygous ENPP1 variants – BOSTON, Oct. 31, 2022 (GLOBE ... Seite 1

Related Keywords

Boston , Massachusetts , United States , Henric Bjarke , Inozyme Pharma Inc , Nasdaq , Mastermind Genomic Search ,

© 2025 Vimarsana